Back to Authors

Chandrasekharan, Subhashini

https://orcid.org/0000-0002-9894-3263

Mayo Clinic

Duke University

Citations 3

“The Top Priority Is a Healthy Baby”: Narratives of Health, Disability, and Abortion in Online Pregnancy Forum Discussions in the US and China
Li, Grace , Chandrasekharan, Subhashini , Allyse, Megan , Allyse, Megan A

Journal of Genetic Counseling | June 9, 2016 | Volume: 26 | Issue: 1 | Pages: 32-39

10.1007/s10897-016-9976-3 Get It

AbstractThe introduction of cell‐free DNA prenatal genetic screening has rekindled discussion of ethical and social questions surrounding prenatal testing, perceptions of disability, and abortion. The growing use of prenatal genetic screening presents a unique opportunity to assess decision‐making around new methods of prenatal testing; especially as there is little available research comparing individual and cultural differences that affect a pregnant woman's decision‐making on prenatal testing. We performed a content analysis of online pregnancy forums in the United States and Mainland China. Content from January 2012 to December 2013 was identified through search methodologies and refined to remove duplication. China‐based content was translated by a native Mandarin speaker. We used qualitative analysis methods to identify common themes in the dataset. There were 333 English responses and 519 Mandarin responses. Three main themese were identified in the data: decision making factors, attitude towards the pregnancy, and attitudes towards abortion. Women's narratives reflected how broader social forces can have an impact on intimate personal decision‐making. Women in the Mandarin dataset evoked stronger narratives of community and/or family decision‐making in pregnancy and were more accepting of the possibility of abortion in the event of a finding of fetal abnormality. Narrative in the English dataset more frequently evoked ideas of unconditional love, regardless of fetal diagnosis, but also acknowledged much stronger support services for individuals with disability and less awareness of stigma. These results highlight the necessity of awareness around how broader cultural and social factors can consciously or unconsciously impact women's decisions and highlight potential focus areas for future counseling efforts.
Impact of the increased adoption of prenatal cfDNA screening on non-profit patient advocacy organizations in the United States
Meredith, Stephanie , Kaposy, Christopher, Miller, Victoria J., Allyse, Megan , Chandrasekharan, Subhashini , Michie, Marsha , Coalition, on behalf of the Prenatal Testing PAG, Kaposy, Chris , Coalition, on behalf of the Prenatal Testing PAG, Allyse, Megan A

Prenatal Diagnosis | May 31, 2016 | Volume: 36 | Issue: 8 | Pages: 714-719

10.1002/pd.4849 Get It

Noninvasive Prenatal Genetic Testing: Current and Emerging Ethical, Legal, and Social Issues
Minear, Mollie , Alessi, Stephanie A., Allyse, Megan , Michie, Marsha , Chandrasekharan, Subhashini , Allyse, Megan A

Annual Review of Genomics and Human Genetics | August 31, 2015 | Volume: 16 | Issue: 1 | Pages: 369-398

10.1146/annurev-genom-090314-050000 Get It

Noninvasive prenatal genetic testing (NIPT) for chromosomal aneuploidy involving the analysis of cell-free fetal DNA became commercially available in 2011. The low false-positive rate of NIPT, which reduces unnecessary prenatal invasive diagnostic procedures, has led to broad clinician and patient adoption. We discuss the ethical, legal, and social issues raised by rapid and global dissemination of NIPT. The number of women using NIPT is anticipated to expand, and the number of conditions being tested for will continue to increase as well, raising concerns about the routinization of testing and negative impacts on informed decision making. Ensuring that accurate and balanced information is available to all pregnant women and that access to NIPT is equitable will require policy guidance from regulators, professional societies, and payers. Empirical evidence about stakeholders' perspectives and experiences will continue to be essential in guiding policy development so that advances in NIPT can be used effectively and appropriately to improve prenatal care.